Femme: Evaluation of antimicrobial, antiadhesive and co-aggregation activity against different urogenital pathogens
The urogenital microbiota is dominated by Lactobacillus that, together with Bifidobacterium, creates a physiological barrier counteracting pathogen infections. The aim of this study was to evaluate the efficacy of Femme to inhibit adhesion and growth of urogenital pathogens.
The antimicrobial and antiadhesive properties of the probiotic strains and their mixture were evaluated on human vaginal epithelium infected with Candida glabrata, Neisseria gonorrheae, Trichomonas vaginalis, and Escherichia coli-infected human bladder epithelium.
Femme is able to compete and prevent the development of the most common urogenital pathogens. In particular, the production of antimicrobial substances, the competition in adhesion to the epithelial cells, and the co-aggregation ability could explain their mechanism of action in counteracting pathogens infection.
Discover more about Femme in this clinical study!
February 13th, 2023